Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Whole transcriptome sequencing for wild type and IRAIN over-expression K562 cells

ABSTRACT: Whole transcriptome sequencing for wild type and IRAIN over-expression K562 cells

PROVIDER: PRJNA1098625 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28611421_1.fastq.gz	Fastqsanger.gz
	SRR28611421_2.fastq.gz	Fastqsanger.gz
	SRR28611422_1.fastq.gz	Fastqsanger.gz
	SRR28611422_2.fastq.gz	Fastqsanger.gz
	SRR28611423_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

RNA-Seq of wild-type HEK293 and K562 celllines

Project description:RNA-Seq of wild-type HEK293 and K562 celllines

| PRJEB7858 | ENA

Whole transcriptome sequencing for wild type and IRAIN over-expression K562 cells

Project description:The development of tyrosine kinase inhibitors (TKIs) has revolutionarily increased the overall survival of patients with chronic myeloid leukemia (CML). However, drug resistance remains a major obstacle. Here, we demonstrated that a BCR-ABL1-independent long non-coding RNA, IRAIN, is constitutively expressed at low levels in CML, resulting in imatinib resistance. IRAIN knockdown decreased the sensitivity of CD34+ CML blasts and cell lines to imatinib, whereas IRAIN overexpression significantly increased sensitivity. Mechanistically, IRAIN downregulates CD44, a membrane receptor favorably affecting TKI resistance, by binding to the nuclear factor kappa B subunit p65 to reduce the expression of p65 and phosphorylated p65. Therefore, the demethylating drug decitabine, which upregulates IRAIN, combined with imatinib, formed a dual therapy strategy which can be applied to CML with resistance to TKIs.

2024-04-13 | GSE263645 | GEO

Expression data from wild type, CBFB-MYH11-overexpressing, DNMT3A knockdown and RUNX1 knockdown K562 cells

Project description:Expression data from wild type, CBFB-MYH11-overexpressing, DNMT3A knockdown and RUNX1 knockdown K562 cells

| PRJNA717368 | ENA

Differentially expressed genes analysis of wild type K562 cells treated with vandetanib and control (DMSO)

Project description:Differentially expressed genes analysis of wild type K562 cells treated with vandetanib and control (DMSO)

| PRJNA665502 | ENA

Transcriptome Profiling of Wild-type vs. A1CF -/- Mouse Whole Kidneys

Project description:Transcriptome Profiling of Wild-type vs. A1CF -/- Mouse Whole Kidneys

| PRJNA427594 | ENA

CD32A Immunoprecipitation in K562 Cell Membrane and Cytoplasm Fractions

Project description:Here we interrogate CD32A protein interactions in the cytoplasm and membrane fractions isolated from the human AML cell lines K562 wild-type and knockout for CD32A. Cells were fractionated prior to incubation with CD32A antibody and subsequent samples isolated using protein agarose beads.

2023-09-05 | PXD042514 | Pride

Transcriptome profiles of wild-type, IRF8KO microglia

Project description:Transcriptome profiles of wild-type, IRF8KO microglia

| PRJNA1107154 | ENA

Transcriptome sequencing of Brassica of Wild Type

Project description:Transcriptome sequencing of Brassica of Wild Type

| PRJNA791549 | ENA

Expression data from Ribonuclease Inhibitor (RI/Rnh1) deficient Human K562 cells

Project description:Summary: Ribonuclease Inhibitor (RI also known as Rnh1) is a 50 kDa, ubiquitously expressed leucine-rich repeat (LRR) protein. It is localized in cytosol and binds to pancreatic-type ribonucleases and inhibit their function. However, the entire biological role for Rnh1 is unknown. We generated RNH1 knock out K562 cells by CRISPR/Cas9 method. Here we studied differential gene expression from wild type and RNH1 knock out K562 cells by RNA-Seq analysis. Overall design: Total RNA was isolated from wild type and RNH1 deficient K562 cells.

2017-03-05 | E-MTAB-5162 | biostudies-arrayexpress

Whole genome expression profiling of Brassica juncea BnCRY2aOE transgenics vis-à-vis wild-type

Project description:The BnCRY2aOE transgenics over-expressing a blue light photoreceptor (BnCRY2a) flowered earlier than wild-type plants by more than two weeks. To identify the downstream candidate genes involved in regulating the early flowering phenotype in the transgenics, a genome-wide microarray analysis of the transgenic plant vs. wild type was performed. The microarray data analysis revealed the differential up-regulation of many genes involved in flower development, cell growth and differentiation and hormone biosynthesis/signalling in comparison to wild-type.

2016-12-31 | GSE81459 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data